NBT Analytics Competitors and Similar CompaniesClear all

NBT Analytics's competitors and similar companies include Opko Health, IntegraGen and Sysmex Inostics.

	NBT Analytics NBT Analytics is a company that provides EEG (electroencephalography) analysis for clinical trials.	Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.	IntegraGen IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.	Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
Founding Date	Founding Date 2015	Founding Date 2007	Founding Date 2000	Founding Date 2008
Type	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma
Locations	Locations Amsterdam, NL HQ	Locations Miami, US HQ Woburn, US	Locations Évry, FR HQ Cambridge, US	Locations Hamburg, DE HQ Kobe, JP Baltimore, US
Employees	Employees 1	Employees 6,0967% increase	Employees 4420% decrease	Employees 65
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.1 b	Valuation ($) 3.8 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $606.9m (FY, 2025)	Revenue (est.) €5m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $400.9m (FY, 2025)	Cost of goods €1.8m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $205.9m (FY, 2025)	Gross profit €3.5m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($225.7m) (FY, 2025)	Net income (€2.7m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 31m	Total funding raised $ 14.3m	Total funding raised N/A